Exercise to Slow Cardiovascular Ageing Progression
1 other identifier
observational
450
1 country
1
Brief Summary
In ageing, deleterious alterations in cardiovascular (CV) structure and function increase risks of ageing-related cardiovascular disease (CVD). Investigators found that these CV alterations were associated with circulating serum metabolites, suggesting a metabolic basis to CV ageing. Investigators hypothesize that modification of these metabolites by intervention, such as exercise, may retard CV alterations and reduce CVD in ageing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 10, 2023
CompletedFirst Posted
Study publicly available on registry
March 20, 2023
CompletedStudy Start
First participant enrolled
May 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2050
June 5, 2025
April 1, 2025
3.7 years
February 10, 2023
June 3, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Metabolite profiles
To measure changes in serum metabolite levels among participants pre and post exercise intervention.
12 Months
Cardiovascular structure and function
To measure changes in CV structure and function (diastolic function, arterial stiffness) among participants.
12 Months
Study Arms (4)
A
1. Cardiovascular measurements Non-invasive brachial blood pressure machine Echocardiography 2. Bio-specimen collection 3. Six-minute walk test 4. Musculoskeletal Analysis 5. Cardiopulmonary exercise test
B
1. Cardiovascular measurements Non-invasive brachial blood pressure machine Echocardiography 2. Bio-specimen collection 3. Six-minute walk test 4. Musculoskeletal Analysis
C
1. Cardiovascular measurements Non-invasive brachial blood pressure machine Echocardiography 2. Bio-specimen collection 3. Six-minute walk test 4. Musculoskeletal Analysis
D
1. Cardiovascular measurements Non-invasive brachial blood pressure machine Echocardiography 2. Bio-specimen collection 3. Six-minute walk test (may require separate day visit to complete) 4. Musculoskeletal Analysis 5. Questionnaires
Eligibility Criteria
Recruited through research studies and community studies.
You may qualify if:
- Age \>=21 years old
- Outdoor ambulant
You may not qualify if:
- Wheelchair or bed-bound
- Dementia
- Residing in sheltered or nursing home
- Cancer
- Participation in ongoing clinical trials that involve interventional drugs or devices
- Aneurysms
- Acute infections (in the last six months)
- Uncontrolled thyrotoxicosis
- Neuromuscular, musculoskeletal or rheumatoid disorders that are exacerbated by exercise
- Uncontrolled asthma or chronic lung disease
- Restrictive lung disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Heart Centre Singapore
Singapore, Singapore, 169609, Singapore
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 10, 2023
First Posted
March 20, 2023
Study Start
May 1, 2023
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2050
Last Updated
June 5, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share